View Document Preview and Link Document Date: 2014-12-01 00:40:30 Open Document File Size: 252,57 KB Share Result on Facebook
City Perth / / Company Foundation Ambassador and son / Drusen Photoreceptors RPE Bruch / AMD / / Continent Europe / / Country Switzerland / Germany / Japan / United States / Australia / United Kingdom / Denmark / / Currency USD / / Event FDA Phase / Person Communication and Meetings / / Facility University College London / Penn State College of Medicine / Sydney Opera House / / IndustryTerm manufacturing dossier / low energy / manufacturing process / energy / Waste products / toxic waste products / digested food / / MedicalCondition particular disease / wet macular degeneration / macular degeneration / very complex disease / age-related macular degeneration / Stargardt’s disease / serious diseases / cancer / disease / early macular degeneration / why macular degeneration / diseases / dry macular degeneration / earlier stage disease / inflammation / / MedicalTreatment radiation / Gene therapy / laser treatment / / Organization Pharmaceutical Benefits Advisory Committee / University College London / Therapeutic Goods Administration / Macular Disease Foundation Australia / FDA / College of Medicine / National Health & Medical Research Council / / Person Shinya Yamanaka / Jan Utzon / Safety / Jørn Utzon / / / Position eye specialist / optometrist / Governor General / designer / Ambassador / / Product Lucentis / Choroid If waste products / Choroid If / AMD / / ProvinceOrState Maryland / / Technology radiation / X-ray / Stem cells / Gene therapy / laser / / URL www.mdfoundation.com.au / / SocialTag 
Macular Degeneration Research Update December 2014 Macular Disease Foundation Australia strongly supports Australia’s contribution to the enormous global research effort underway to better understand why macular degene